C12Y 402/01001
Carbonate dehydratase , i.e. carbonic anhydrase
Official title: Carbonate dehydratase (4.2.1.1), i.e. carbonic anhydrase
C12Y402/01001 (Carbonate dehydratase , i.e. carbonic anhydrase) appears on 77 US grants and 150 published applications in this corpus.
Search patents in C12Y- Granted patents
- 77
- Published applications
- 150
- Assignees
- 84
- Inventors
- 393
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 2 | 1 |
| 2010 | 0 | 4 |
| 2011 | 0 | 2 |
| 2012 | 1 | 7 |
| 2013 | 4 | 7 |
| 2014 | 4 | 6 |
| 2015 | 2 | 10 |
| 2016 | 7 | 5 |
| 2017 | 2 | 9 |
| 2018 | 6 | 11 |
| 2019 | 7 | 6 |
| 2020 | 10 | 6 |
| 2021 | 6 | 15 |
| 2022 | 1 | 10 |
| 2023 | 8 | 10 |
| 2024 | 4 | 14 |
| 2025 | 6 | 10 |
| 2026 | 7 | 13 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Engineered autotrophic bacteria for CO2 conversion to organic materials28 Jul 2026US 12,692,519 B2Yeda Research and Development Co. Ltd.
- Enzyme-decorated nanocatalysts9 Jun 2026US 12,649,150 B2Cassiopea S.P.A.
- CA2-IL15 fusion proteins for tunable regulation2 Jun 2026US 12,642,792 B2Obsidian Therapeutics, Inc.
- Recombinant host cells for the production of malonate26 May 2026US 12,637,680 B2Lygos, Inc.
- CA2 compositions and methods for tunable regulation19 May 2026US 12,630,599 B2Obsidian Therapeutics, Inc.
- Method for producing solution and solution1 Oct 2026US 2026/0297641 A1Honda Motor Co., Ltd.
- Modified antibodies and uses thereof17 Sep 2026US 2026/0274934 A1Gat Biosciences, S.L.
- Trogocytosis in cancer cells and methods for treating cancer related thereto17 Sep 2026US 2026/0274990 A1Arizona Board of Regents on Behalf of the University of Arizona
- Enzyme-Decorated Nanocatalysts3 Sep 2026US 2026/0257211 A1Cassiopea S.P.A.
- Method of sequestering atmospheric carbon27 Aug 2026US 2026/0249241 A1Fabricnano Limited
Most cited
By later US patents
- Genetically modified organisms for increased microbial production of 3-hydroxypropionic acid involving an oxaloacetate alpha-decarboxylase57US 8,809,027 B1OPX Biotechnologies, Inc. · 2014
- Bicyclic peptide ligands and uses thereof20US 10,857,196 B2BicycleTx Limited · 2020
- Bicyclic peptide ligands and uses thereof17US 11,241,473 B2BicycleTx Limited · 2022
- RNAi-mediated inhibition of ocular targets15US 7,592,324 B2Alcon Inc. · 2009
- Process for CO2 capture using carbonates and biocatalysts with absorption of CO2 and desorption of ion-rich solution9US 8,722,391 B2CO2 Solutions Inc. · 2014